Home
HelpTest Code MITAN Mitotane, Plasma
Additional Codes
| Epic Ordering Code | LAB3041462 |
| NBS code | LBC13322 |
| Service code | 36876 |
Reporting Name
Mitotane, PSpecimen Type
Plasma Na HeparinShipping Instructions
Ship specimen refrigerated.
Specimen Required
Collection Container/Tube: Green top (sodium heparin) (Lithium heparin and PST/plasma gel tubes are not acceptable.)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Within 2 hours of collection, centrifuge and aliquot plasma into plastic vial.
NUH Outreach Laboratories:
Specimen Requirements
Submit the following:
Container: Dark Green Top (Na Heparin)
Processing Requirements
Centrifuge and aliquot plasma into a Mayo plastic tube.
Specimen type: Plasma
Volume: 1 mL
Storage/transport requirements: Refrigerated
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Plasma Na Heparin | Refrigerated (preferred) | 21 days |
| Frozen | 28 days | |
| Ambient | 72 hours |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
| Gross icterus | OK |
Method Name
Gas Chromatography Mass Spectrometry (GC-MS) Confirmation with Quantitation
Day(s) Performed
Tuesday, Thursday
Report Available
2 to 7 daysPlease note that this is a referral test requiring transport to the external testing facility and an additional 3-5 days is required.
Reference Values
Therapeutic: 14-20 mcg/mL
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Useful For
Assessing compliance or making dosage adjustments for mitotane
CPT Code Information
80299
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| MITAN | Mitotane, P | 13626-7 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 621811 | Mitotane, P | 13626-7 |
Secondary ID
621811Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Last updated 04/08/2026